RRC
50
4
ETR
66
3
BBY
45
3
BRK.B
27
2
GS
63
11
SJM
19
5
HPQ
53
3
PH
71
4
NKE
30
2
ICE
57
2
ESS
56
5
CMS
57
3
DGX
36
3
RIG
58
3
BEN
34
6
ISRG
71
2
L
51
5
YUM
43
5
VLO
33
3
XOM
42
2
RRC
50
4
ETR
66
3
BBY
45
3
BRK.B
27
2
GS
63
11
SJM
19
5
HPQ
53
3
PH
71
4
NKE
30
2
ICE
57
2
ESS
56
5
CMS
57
3
DGX
36
3
RIG
58
3
BEN
34
6
ISRG
71
2
L
51
5
YUM
43
5
VLO
33
3
XOM
42
2
Financhill
Back

Zevra Therapeutics Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
67

ZVRA
Zevra Therapeutics

Last Price:
8.81
Seasonality Move:
3.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Zevra Therapeutics Stock Forecast

  • Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 16.6% based on the past 9 years of stock performance.
  • Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
  • Is Zevra Therapeutics Stock Undervalued?
    The current Zevra Therapeutics [ZVRA] share price is $8.61. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Zevra Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 16.6% based on the past 9 years of stock performance.

Zevra Therapeutics Stock Rating

Buy
67
Zevra Therapeutics (ZVRA) is a Buy

Is Zevra Therapeutics overpriced?

  • Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

Zevra Therapeutics Stock Price History

Is ZVRA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com

52-Week Data

52-Week High:
8.95
52-Week Low:
3.89

Prediction Charts

Market Cap:
453.04M
Price in USD:
8.61
Volume:
426.01K
Beta:
1.81

Technical Analysis

SMA50:
7.79
SMA100:
6.90
SMA200:
6.16
52-Wk Change:
85.96%

Stock Predictions

  • Is Zevra Therapeutics stock public?
    Yes, Zevra Therapeutics is a publicly traded company.
  • What is the Zevra Therapeutics stock quote today?
    The Zevra Therapeutics stock price is 8.61 USD today.
  • How to buy Zevra Therapeutics stock online?
    You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-17 8.55 8.53 8.68 8.41
Oct-18 8.51 8.49 8.69 8.38
Oct-21 8.48 8.54 8.66 8.35
Oct-22 8.49 8.34 8.62 8.30
Oct-23 8.30 8.01 8.34 7.93
Oct-24 7.99 7.90 8.09 7.85
Oct-25 7.92 7.75 8.02 7.67
Oct-28 7.78 8.05 8.15 7.71
Oct-29 8.10 8.26 8.28 7.97
Oct-30 8.17 8.43 8.58 8.11
Oct-31 8.38 8.16 8.53 8.14
Nov-1 8.17 8.40 8.66 8.17
Nov-4 8.32 8.55 8.67 8.22
Nov-5 8.54 8.61 8.65 8.26

Zevra Therapeutics Earnings

Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Zevra Therapeutics Forecast Revenue Growth

Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $1.26 per share.

* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.